
Vitamin D High Doses Do Not Cut Acute COVID Risk, But May Hint at Long COVID Benefit
A large randomized trial (VIVID) found that high-dose vitamin D3 did not reduce short-term COVID-19 severity, hospitalizations, or transmission. However, among participants who consistently took the supplement, there was a borderline-significant reduction in long COVID symptoms at eight weeks (21% vs 25%), suggesting a possible benefit that warrants further study.













